Author

Jérome Viala 1

1 Hôpital Robert Debré,Gastroentérologie pédiatrique,Paris,France

INFLIXIMAB INDUCED PSORIASIS IN A COHORT OF CHILDREN WITH INFLAMMATORY BOWEL DISEASE : A 12 YEARS FOLLOW-UP STUDY.

Christine Martinez-Vinson, Olivier Courbette, Camille Aupiais, Jérome Viala, Jean-Pierre Hugot

Management of Peutz-Jeghers Syndrome in Children and Adolescents: A Position Paper From the ESPGHAN Polyposis Working Group

Andrew Latchford, Shlomi Cohen, Marcus Auth, Michele Scaillon, Jérome Viala, Richard Daniels, Cecile Talbotec, Thomas Attard, Carol Durno, Warren Hyer

Paediatric Gastrointestinal Endoscopy: European Society for Paediatric Gastroenterology Hepatology and Nutrition and European Society of Gastrointestinal Endoscopy Guidelines

Mike Thomson, Andrea Tringali, Jean-Marc Dumonceau, Marta Tavares, Merit Tabbers, Raoul I. Furlano, Manon C.W. Spaander, Cesare Hassan, Christos Tzvinikos, Hanneke IJsselstijn, Jérome Viala, Luigi Dall'Oglio, Marc A. Benninga, Rok Orel, Yvan Vandenplas, Radan Keil, Claudio Romano, Eva Brownstone, Štěpán Hlava, Patrick Ge

SUBCUTANEOUS USTEKINUMAB PROVIDED CLINICAL AND BIOLOGICAL BENEFIT FOR 9/12 REFRACTORY PEDIATRIC CROHN'S DISEASE

Christine Martinez-Vinson, Jean-Pierre Hugot, Marc Bellaiche, Jérome Viala

TROUGH LEVELS TO INFLIXIMAB  AT W6 ARE PREDICTIVE OF REMISSION AT W14, IN PEDIATRIC CROHN DISEASE.

Christine Martinez-Vinson, Olivier Courbette, Camille Aupiais, Jérome Viala, Jean-Pierre Hugot

Item 1 - 5 / 5
1